Cargando…

Association between Individual Norepinephrine Transporter (NET) Availability and Response to Pharmacological Therapy in Adults with Attention-Deficit/Hyperactivity Disorder (ADHD)

Background: The role of the norepinephrine transporter (NET) has received increased focus in recent studies on the pathogenesis of attention-deficit/hyperactivity disorder (ADHD). The predictive value for pharmacological treatment and its link to other health or social limitations has been little-st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Jue, Mauche, Nicole, Rullmann, Michael, Ulke, Christine, Becker, Georg-Alexander, Patt, Marianne, Zientek, Franziska, Hesse, Swen, Sabri, Osama, Strauß, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331391/ https://www.ncbi.nlm.nih.gov/pubmed/35892406 http://dx.doi.org/10.3390/brainsci12080965

Ejemplares similares

Adult attention-deficit/hyperactivity disorder is associated with reduced norepinephrine transporter availability in right attention networks: a (S,S)-O-[(11)C]methylreboxetine positron emission tomography study
por: Ulke, Christine, et al.
Publicado: (2019)

Higher HbA1c levels associate with lower hippocampal serotonin transporter availability in non-diabetic adults with obesity
por: Grundmann, Rico, et al.
Publicado: (2020)

Brain arousal regulation and depressive symptomatology in adults with attention-deficit/hyperactivity disorder (ADHD)
por: Huang, Jue, et al.
Publicado: (2019)

HPA Axis Responsiveness Associates with Central Serotonin Transporter Availability in Human Obesity and Non-Obesity Controls
por: Schinke, Christian, et al.
Publicado: (2022)

Central Serotonin/Noradrenaline Transporter Availability and Treatment Success in Patients with Obesity
por: Griebsch, Nora-Isabell, et al.
Publicado: (2022)

Oral Health-Related Quality of Life in Adult Patients with Depression or Attention Deficit Hyperactivity Disorder (ADHD)
por: Gemp, Stephan, et al.
Publicado: (2023)

Availability of Central α4β2* Nicotinic Acetylcholine Receptors in Human Obesity
por: Schweickert de Palma, Eva, et al.
Publicado: (2022)

Association of norepinephrine transporter methylation with in vivo NET expression and hyperactivity–impulsivity symptoms in ADHD measured with PET
por: Sigurdardottir, H. L., et al.
Publicado: (2019)

Suppressed Fat Appetite after Roux-en-Y Gastric Bypass Surgery Associates with Reduced Brain μ-opioid Receptor Availability in Diet-Induced Obese Male Rats
por: Hankir, Mohammed K., et al.
Publicado: (2017)

Increased pulmonary serotonin transporter in patients with chronic obstructive pulmonary disease who developed pulmonary hypertension
por: Frille, Armin, et al.
Publicado: (2020)

Changes of central noradrenaline transporter availability in immunotherapy-naïve multiple sclerosis patients
por: Schmidt, Elisa, et al.
Publicado: (2020)

Current radiotracers to image neurodegenerative diseases
por: Tiepolt, Solveig, et al.
Publicado: (2019)

Gender differences in adult ADHD: Cognitive function assessed by the test of attentional performance
por: Stibbe, Tina, et al.
Publicado: (2020)

Atomoxetine for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children with ADHD and dyslexia
por: Sumner, Calvin R, et al.
Publicado: (2009)

Developmental psychopathology: Attention Deficit Hyperactivity Disorder (ADHD)
por: Schmidt, Sören, et al.
Publicado: (2009)

Emotional dysregulation and attention deficit hyperactivity disorder (ADHD)
por: Turkia, I. Ben, et al.
Publicado: (2021)

Emotional Intelligence and Attention-deficit/hyperactivity disorder (ADHD)
por: Ben Turkia, I., et al.
Publicado: (2023)

The 1287 G/A polymorphism of the Norepinephrine Transporter gene (NET) is involved in Commission Errors in Korean children with Attention Deficit Hyperactivity Disorder
por: Song, Dong-Ho, et al.
Publicado: (2011)

Effect of Atomoxetine on Hyperactivity in an Animal Model of Attention-Deficit/Hyperactivity Disorder (ADHD)
por: Moon, Su Jin, et al.
Publicado: (2014)

Central Noradrenergic Neurotransmission and Weight Loss 6 Months After Gastric Bypass Surgery in Patients with Severe Obesity
por: Soeder, J. Marvin, et al.
Publicado: (2021)

Effects of norepinephrine transporter gene variants on NET binding in ADHD and healthy controls investigated by PET
por: Sigurdardottir, Helen L., et al.
Publicado: (2015)

Is it Attention Deficit Hyperactivity Disorder (ADHD) or Stimulant use disorder ? How is ADHD diagnosed?
por: Sud, N.
Publicado: (2022)

Serotonin transporter gene promoter methylation status correlates with in vivo prefrontal 5-HTT availability and reward function in human obesity
por: Drabe, M, et al.
Publicado: (2017)

Attention-Deficit/Hyperactivity Disorder (ADHD) and High Risk Behaviors
por: Bakhshani, Nour-Mohammad
Publicado: (2013)

Dietary Patterns in Children with Attention Deficit/Hyperactivity Disorder (ADHD)
por: Woo, Hae Dong, et al.
Publicado: (2014)

Attention-Deficit/Hyperactivity Disorder (ADHD) and Obesity: Update 2016
por: Cortese, Samuele, et al.
Publicado: (2017)

Personality profiles in adults with attention deficit hyperactivity disorder (ADHD)
por: Perroud, Nader, et al.
Publicado: (2016)

A Review of Heterogeneity in Attention Deficit/Hyperactivity Disorder (ADHD)
por: Luo, Yuyang, et al.
Publicado: (2019)

Arousal and Executive Alterations in Attention Deficit Hyperactivity Disorder (ADHD)
por: Martella, Diana, et al.
Publicado: (2020)

Neurotherapeutics for Attention Deficit/Hyperactivity Disorder (ADHD): A Review
por: Rubia, Katya, et al.
Publicado: (2021)

Yoga as an Adjunct Treatment for Attention Deficit Hyperactivity Disorder (ADHD)
por: Srinivas, S., et al.
Publicado: (2023)

Attention deficit hyperactivity disorder (ADHD) & COVID-19: Attention deficit hyperactivity disorder: Consequences of the 1st wave
por: Insa, I., et al.
Publicado: (2021)

A randomised controlled trial of the Neuro Emotional Technique (NET) for childhood Attention Deficit Hyperactivity Disorder (ADHD): a protocol
por: Karpouzis, Fay, et al.
Publicado: (2009)

Involvement of Norepinephrine in the Control of Activity and Attentive Processes in Animal Models of Attention Deficit Hyperactivity Disorder
por: Viggiano, D., et al.
Publicado: (2004)

Sigma-1 and dopamine D2/D3 receptor occupancy of pridopidine in healthy volunteers and patients with Huntington disease: a [(18)F] fluspidine and [(18)F] fallypride PET study
por: Grachev, Igor D., et al.
Publicado: (2020)

Executive and motivational processes in adolescents with Attention-Deficit-Hyperactivity Disorder (ADHD)
por: Toplak, Maggie E, et al.
Publicado: (2005)

Facts, values, and Attention-Deficit Hyperactivity Disorder (ADHD): an update on the controversies
por: Parens, Erik, et al.
Publicado: (2009)

Genetic Epidemiology of Attention Deficit Hyperactivity Disorder (ADHD Index) in Adults
por: Boomsma, Dorret I., et al.
Publicado: (2010)

Attention-deficit hyperactivity disorder (ADHD) stimulant medications as cognitive enhancers
por: Advokat, Claire, et al.
Publicado: (2013)

Prevalence of Adult Attention Deficit Hyperactivity Disorder (Adult ADHD): Tabriz
por: Amiri, Shahrokh, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_lgjqln56pkce9qe85ah0luj8j5